The Supreme Court addressed concerns regarding the implementation of the Uniform Code for Pharmaceutical Marketing Practices (UCPMP) 2024, designed to curb unethical drug promotion. While the Centre asserted the code's strength, the court questioned its effectiveness in practice. The court has scheduled further hearing on October 7 to examine the enforcement of the existing regulatory framework.